Signal Explorer

Same Client Revenue Growing

Pricing Power Services

Insider Buying Quarterly Loan Deposit Growth Comparison Quarterly Dividend Declared Share Repurchase Activity Disclosed Allowance For Loan Losses Disclosure Credit Loss Provision Effective Tax Rate Reconciliation Profitability Metrics Disclosure Basel Iii Capital Ratio Requirements Disclosed Interest Income Year Over Year Comparison Acquisition And Management Fees Disclosed Unrealized Gain Loss Disclosure Weighted Average Interest Rate Disclosed

Institutional Investment Insider Buying Warrant Valued Black Scholes Capital Raising Uncertainty Disclosed Rsu Psu Vesting Schedule Disclosed Lease Rou Incremental Borrowing Rate Disclosure Audit Committee Independence Certification Cybersecurity Risk Management Program Disclosure Board Committee Composition Disclosure Headcount Disclosure Standard Financing Activities Cash Flow Disclosure Competition Disclosure Equity Compensation Accounting Policy Cash Flow Statement Investing Activities

Utilization Improving

Demand Softening

Recurring Revenue Growing Same Client Revenue Growing Dso Deteriorating Backlog Building

Reimbursement Improving Pricing Power Services Volume Inflecting

Burn Rate Controlled Codm Segment Reporting Disclosure Share Repurchase Activity Disclosed Cash Flow Statement Investing Activities Material Weakness In Internal Controls Disclosed Net Loss Reported Ipo Or Capital Raising Completion

Management Exodus

Executive Educational Background Disclosure Classified Board Director Election Board Committee Composition Disclosure Audit Committee Independence Certification Employee Director Compensation Waiver

Employee Director Compensation Waiver

Audit Committee Independence Certification Executive Educational Background Disclosure Non Employee Director Compensation Disclosed Executive Transition Gratitude Statement Patent Family Portfolio Disclosure Director Continuity Stated Classified Board Director Election

Breakthrough Therapy Granted Orphan Status Granted Fast Track Granted Ce Mark Received Fda Breakthrough Device Designation Fast Track Designation Received Kol Endorsement Executive Educational Background Disclosure Executive Transition Gratitude Statement Classified Board Director Election Employee Director Compensation Waiver Rsu Psu Vesting Schedule Disclosed

Accelerated Approval

Clinical Trial Result Indication Expansion

Quarterly Dividend Declared

Institutional Investment Fcpa Compliance Representation Corporate Organization And Standing Representation Merger Proxy Statement Disclosure Share Withholding Tax Settlement New York Jurisdiction Clause Hazardous Materials Definition Erisa Definition Or Compliance Statement Amendment Modification Waiver Clause No Broker Fees Representation Liquidity Position Snapshot Disclosed Use Of Proceeds Disclosure Restrictive Debt Covenants Disclosure Beneficial Ownership Disclaimer Sanctions Compliance Representation

Inventory Writedown Burn Rate Controlled Net Loss Reported Operating Lease Rent Expense Disclosed Reverse Stock Split Effected Liquidity Position Snapshot Disclosed Cash Flow Statement Investing Activities Shares Outstanding Disclosure Depreciation Expense Composition Disclosure Event Of Default Defined Financing Activities Cash Flow Disclosure Ipo Or Capital Raising Completion Warrant Valued Black Scholes Convertible Debt Conversion

Demand Softening

Debt Note Interest Terms Disclosed Fcpa Compliance Representation Corporate Authority Representation Sanctions Compliance Representation Change Of Control Redemption Provision Ipo Or Capital Raising Completion Closing Logistics Specified Debt Note Maturity Date Disclosure Closing Condition Opinions And Certificates Form S3 Shelf Registration Disclosure Indemnification Consent Requirement Corporate Organization And Standing Representation Legal Opinion Methodology Disclosure Legal Opinion Scope Limitation No Regulatory Approval Required

Quarterly Dividend Declared

Same Facility Growth Pricing Power Services Premium Pricing Power Utilization Declining Services

Recurring Revenue Growing Same Client Revenue Growing Usage Growth

Demand Softening

Effective Tax Rate Reconciliation Allowance For Loan Losses Disclosure Basel Iii Capital Ratio Requirements Disclosed Credit Loss Provision Quarterly Dividend Declared Operating Margin Declining Pipeline Softening

Reverse Stock Split Effected Nyse Listing Disclosure Fractional Share Cash Payment

Quarterly Loan Deposit Growth Comparison Basel Iii Capital Ratio Requirements Disclosed Earnings Call Replay Details Profitability Metrics Disclosure

Demand Softening

Ceo Team Pride Statement Earnings Call Qa Segment Executive Transition Gratitude Statement Mineral Exploration Delineation Forward Looking Statement Definition

Financing Activities Cash Flow Disclosure Rsu Psu Vesting Schedule Disclosed Cash Flow Statement Investing Activities Incorporation Or Reincorporation Disclosure Form 8K Filing Disclosure Ip Protection Methods Disclosed Net Loss Reported Operating Lease Rent Expense Disclosed Liquidity Position Snapshot Disclosed Credit Risk Management Disclosure Segment Aggregation Disclosure Other Income Expense Disclosure Depreciation Expense Composition Disclosure Goodwill Acquisition Disclosure Convertible Debt Conversion

Management Exodus

Reverse Stock Split Effected

Burn Rate Controlled Credit Loss Provision Allowance For Loan Losses Disclosure Quarterly Loan Deposit Growth Comparison Share Repurchase Activity Disclosed Profitability Metrics Disclosure Basel Iii Capital Ratio Requirements Disclosed Quarterly Dividend Declared Quarterly Performance Praise Interest Income Year Over Year Comparison

Institutional Investment Form 8K Filing Disclosure

Quarterly Loan Deposit Growth Comparison Basel Iii Capital Ratio Requirements Disclosed Profitability Metrics Disclosure

Management Exodus Clinical Trial Result

Kol Endorsement Director Continuity Stated Executive Transition Gratitude Statement Interim Data Positive Gene Therapy Aav

Ind Submission Planned

Indication Expansion Clinical Hold Lead Asset Progress Clinical Trial Result Combination Therapy Mentioned

Clinical Hold Active

Institutional Investment Safety Differentiated Nyse Listing Disclosure Equity Plan Board Approval Conditional On Shareholder Vote Interim Data Positive Forward Looking Statement Definition Checkpoint Inhibitor Program Board Fairness Determination

Market Price Definition Libor Based Term Loan Pricing Prime Rate Determination Methodology Liquidity Position Snapshot Disclosed

Nyse Listing Disclosure

Board Committee Composition Disclosure Employee Director Compensation Waiver

Record Date Disclosure